The first hypothesis to explain this ‘honeymoon period’ was the concept of ‘β-cell rest.’ It proposed that exogenous insulin administration following T1D onset reduces the demand on β-cells, thereby improving insulin secretion and enhancing β-cell viability (121). This evidence concerns the gene INS and type 1 diabetes mellitus.